Cardinal Health (CAH) PT Raised to $260 at Evercore ISI

Evercore ISI analyst Elizabeth Anderson raised the price target on Cardinal Health (NYSE: CAH) to $260.00 (from $250.00) while maintaining a Outperform rating.

The analyst comments "Reflecting the print and outlook, we are raising FY’26 EPS to $10.36 (from $10.05) and FY’27 EPS to $11.65 (from $11.28), and increasing our price target to $260. Overall, the quarter reinforces confidence in CAH’s ability to sustain earnings growth through operating discipline, specialty exposure, and balanced capital deployment, even as reported growth moderates."

You May Also Be Interested In

• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating